“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
(Visited 43 times, 1 visits today)
Related posts:
China tells U.S. to slow money printing presses
European Union ministers back ban on menthol cigarettes
India’s Poorest Women Coerced Into Sterilization
A Libertarian Testing Ground For Bitcoin, 3D Printers, and Drones
U.S. to Commit $500 Million, Deploy 3,000 Troops in Ebola Fight
World Bank tells Saudis to prop up currency amid global devaluation war
The Top 10 Companies With The Best Business Outlook According To Employees
Doors swing open for advocates of marijuana legalization on Capitol Hill
We need to talk about Europe's 'right to be forgotten': Google
Bankers balk as Postal Service plans payday loans, digital currency
Obama toasts Bush: 'We are surely a kinder and gentler nation because of you'
Russia pulls out of decade-old drug control agreement with U.S.
Marc Faber: S&P 500 Could Fall 20% to 30%
Wholesale Prices in U.S. Climb by Most in a Year; Food Prices Surge
Money laundering investigation stymied by China, Italy says